... if our technology proves 100 % to be the real deal , then Edward's Biosciences absolutely must acquire or partner us ...
Their $US 53 Billion market cap requires them to maintain their market share , or to expand it ... AVR is both those things to them ... EB only has $ 5.2 B. in annual revenue .... even so , they extract a healthy $ 1.5 B. profit from that ...
... other medical companies may eventually want us , but Edward's simply must have us ... sooner or later ...
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)